Short term use of oral benzodiazepines, BZDs, for periprocedural anxiolysis seems to be safe and effective. The 2020 FDA black-box warning should not deter their appropriate use in dermatologic surgery and other low-risk outpatient procedures, says recent research from Ohio State University.
Anxiolysis is also called minimal sedation, conscious sedation, or twilight sedation. Anxiolysis is anxiety relief that occurs after you have been given medicine. This medicine helps you stay calm and comfortable during certain tests or procedures.
Oral benzodiazepines (BZDs) are useful tools for periprocedural anxiolysis. The United States Food and Drug Administration (FDA) recently issued a black-box warning of their risks of abuse and dependence.
Researchers review by evaluating the safety and efficacy of oral BZDs for periprocedural anxiolysis in outpatient dermatologic, plastic surgery, dental, and ophthalmologic procedures performed under local anesthesia.
The research article is published in Dermatologic SurgeryJournal.
Subscribe to PharmaTutor News Alerts by Email
